BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina

Source: Nasdaq GlobeNewswire / 29 Nov 2023 07:00:00   America/New_York